Hirobumi Teraoka

3.7k citations

109 papers · 3.0k indexed · h-index 32

Molecular Biology top 5%
Oncology top 5%
Surgery top 10%
Hepatology top 2%
Cancer Research top 10%

Co-authors: Kinji Tsukada Kinji Asahina Keiko Shimizu‐Saito Kozo Takase Kenichi Teramoto Shigeki Arii Gensaku Okada Ryo Sakasai
Topics: DNA Repair Mechanisms (38 papers)DNA and Nucleic Acid Chemistry (18 papers)Cancer-related Molecular Pathways (14 papers)
Cited by: Hepatology Molecular Biology Oncology
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: Japan United States United Kingdom

In The Last Decade

Hirobumi Teraoka

108 papers receiving 2.9k citations

Peers

Countries citing papers authored by Hirobumi Teraoka

Since Specialization

Citations

This map shows the geographic impact of Hirobumi Teraoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirobumi Teraoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirobumi Teraoka more than expected).

Fields of papers citing papers by Hirobumi Teraoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirobumi Teraoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirobumi Teraoka. The network helps show where Hirobumi Teraoka may publish in the future.

Co-authorship network of co-authors of Hirobumi Teraoka

This figure shows the co-authorship network connecting the top 25 collaborators of Hirobumi Teraoka. A scholar is included among the top collaborators of Hirobumi Teraoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirobumi Teraoka. Hirobumi Teraoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Arf/p53 Protein Module, Which Induces Apoptosis, Down-regulates Histone H2AX to Allow Normal Cells to Survive in the Presence of Anti-cancer Drugs 2013 ·Journal of Biological Chemistry ·(unknown),(unknown),(unknown),Eiji Sugihara,Ryo Sakasai,Hiroaki Fujimori,Hirobumi Teraoka,Hideyuki Saya,Masamoto Kanno,Fumio Tashiro,Hitoshi Nakagama,Mitsuko Masutani,Kenichi Yoshioka	25
2	Hepatic stellate cells mediate differentiation of dendritic cells from monocytes. 2012 ·PubMed ·(unknown),Sei Kakinuma,Kinji Asahina,Keiko Shimizu‐Saito,Shigeki Arii,Yujiro Tanaka,Hirobumi Teraoka	2
3	Onset of Quiescence Following p53 Mediated Down-Regulation of H2AX in Normal Cells 2011 ·PLoS ONE ·(unknown),Hiroaki Fujimori,Hirokazu Fukuda,(unknown),(unknown),(unknown),Mima Shikanai,Yosuke Ichijima,(unknown),Shuki Mizutani,Naoto Tsuchiya,Yoshitaka Hippo,Hitoshi Nakagama,Mitsuko Masutani,Hirobumi Teraoka,Kenichi Yoshioka	33
4	A novel method of mouse ex utero transplantation of hepatic progenitor cells into the fetal liver 2009 ·Biochemical and Biophysical Research Communications ·Mima Shikanai,Kinji Asahina,Sachiko Iseki,Kenichi Teramoto,(unknown),Keiko Shimizu‐Saito,Masato S. Ota,Kazuhiro Eto,Hirobumi Teraoka	2
5	Role of Parp-1 in suppressing spontaneous deletion mutation in the liver and brain of mice at adolescence and advanced age 2009 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Atsushi Shibata,Daisuke Maeda,Hideki Ogino,Masahiro Tsutsumi,Takehiko Nohmi,Hitoshi Nakagama,Takashi Sügimura,Hirobumi Teraoka,Mitsuko Masutani	20
6	Vascular endothelial growth factor promotes proliferation and function of hepatocyte-like cells in embryoid bodies formed from mouse embryonic stem cells 2008 ·Journal of Hepatology ·Hiroaki Fujimori,Kinji Asahina,Keiko Shimizu‐Saito,Reiko Ikeda,Yujiro Tanaka,Kenichi Teramoto,Ikuo Morita,Hirobumi Teraoka	13
7	Hepatic Progenitor Cells in the Mouse Extrahepatic Bile Duct after a Bile Duct Ligation 2007 ·Stem Cells and Development ·Takumi Irie,Kinji Asahina,Keiko Shimizu‐Saito,Kenichi Teramoto,Shigeki Arii,Hirobumi Teraoka	13
8	The intrinsic structure of glucose transporter isoforms Glut1 and Glut3 regulates their differential distribution to detergent‐resistant membrane domains in nonpolarized mammalian cells 2007 ·FEBS Journal ·(unknown),Hiroaki Naraba,Hirobumi Teraoka,Takayuki Kitagawa	10
9	Embryonic Stem Cells: Hepatic Differentiation and Regenerative Medicine for the Treatment of Liver Disease 2006 ·Current Stem Cell Research & Therapy ·Kinji Asahina,Kenichi Teramoto,Hirobumi Teraoka	18
10	Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells 2005 ·Biochemical and Biophysical Research Communications ·Takahiko Kobayashi,Hiroyuki Tanaka,Hitoshi Kuwana,Seiji Inoshita,Hirobumi Teraoka,Sei Sasaki,Yoshio Terada	86
11	Hepatocyte differentiation from embryonic stem cells and umbilical cord blood cells 2005 ·Journal of Hepato-Biliary-Pancreatic Surgery ·Kenichi Teramoto,Kinji Asahina,(unknown),Sei Kakinuma,(unknown),Keiko Shimizu‐Saito,Yujiro Tanaka,Hirobumi Teraoka,Shigeki Arii	29
12	Generation of hybrid hepatocytes by cell fusion from monkey embryoid body cells in the injured mouse liver 2005 ·Histochemistry and Cell Biology ·(unknown),Kinji Asahina,Hiroaki Fujimori,(unknown),Keiko Shimizu‐Saito,Yujiro Tanaka,Kenichi Teramoto,Shigeki Arii,Kozo Takase,Miho Kataoka,Yoshinori Soeno,Chise Tateno,Katsutoshi Yoshizato,Hirobumi Teraoka	21
13	Poly(ADP-ribose) polymerase-1 inhibits ATM kinase activity in DNA damage response 2004 ·Biochemical and Biophysical Research Communications ·Fumiaki Watanabe,Hidesuke Fukazawa,Mitsuko Masutani,Hiroshi Suzuki,Hirobumi Teraoka,Shuki Mizutani,Yoshimasa Uehara	22
14	DNA ligase IV from a basidiomycete, Coprinus cinereus, and its expression during meiosis 2003 ·Microbiology ·Satoshi H. Namekawa,Yosuke Ichijima,Fumika N. Hamada,Nobuyuki Kasai,Kazuki Iwabata,Takayuki Nara,Hirobumi Teraoka,Fumio Sugawara,Kengo Sakaguchi	11
15	Expression of Cyclin‐dependent Kinase Inhibitor p27/Kipl and AP‐1 Coactivator p38/Jabl Correlates with Differentiation of Embryonal Rhabdomyosarcoma 2002 ·Japanese Journal of Cancer Research ·Rika Tsuchida,Jun Miyauchi,Lisong Shen,Masatoshi Takagi,Yukiko Tsunematsu,Morihiro Saeki,Toshiro Honna,Seiko Yamada,Hirobumi Teraoka,Jun‐ya Kato,Shuki Mizutani	13
16	Phosphorylation of Human General Transcription Factors TATA‐Binding Protein and Transcription Factor IIB by DNA‐Dependent Protein Kinase 1997 ·European Journal of Biochemistry ·Taku Chibazakura,Fumiaki Watanabe,Shigetaka Kitajima,Kinji Tsukada,Yukio Yasukochi,Hirobumi Teraoka	37
17	Hypomutability by y-rays of thymic lymphoma cells derived from a SCID mouse 1996 ·Journal of Radiation Research ·(unknown),Kouichi Tatsumi,Masahiro Muto,Hirobumi Teraoka,Fumiaki Watanabe,Toshiaki Ogiu	1
18	CPP32/Yama/apopain cleaves the catalytic component of DNA‐dependent protein kinase in the holoenzyme 1996 ·FEBS Letters ·Hirobumi Teraoka,(unknown),Fumiaki Watanabe,Kinji Tsukada,Akira Suwa,Masato Enari,Shigekazu Nagata	32
19	OK-1035, a Selective Inhibitor of DNA-Dependent Protein Kinase 1995 ·Biochemical and Biophysical Research Communications ·Yukinori Take,(unknown),(unknown),Hiroshi Fukatsu,Hirobumi Teraoka,(unknown),Ayako Okuyama	28
20	Expression of c-fos and c-myc in Raji Burkitt's lymphoma cells during the progression of DMSO-induced G1 cells into S phase 1991 ·Experimental Cell Research ·Hirobumi Teraoka,(unknown),Kozo Takase,Kohtaro Yamamoto,(unknown),(unknown),Kinji Tsukada	13

About Hirobumi Teraoka

Hirobumi Teraoka is a scholar working on Hepatology, Molecular Biology and Oncology, having authored 109 papers that have together received 3.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (38 papers), DNA and Nucleic Acid Chemistry (18 papers) and Cancer-related Molecular Pathways (14 papers). The work is most often cited by research in Hepatology (417 citations), Molecular Biology (2.4k citations) and Oncology (655 citations). Hirobumi Teraoka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kinji Tsukada, Kinji Asahina, Keiko Shimizu‐Saito, Kozo Takase, Kenichi Teramoto, Shigeki Arii, Gensaku Okada, Ryo Sakasai, Yujiro Tanaka and Fumiaki Watanabe. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact